Clinical and forensic signs related to opioids abuse

Current Drug Abuse Reviews

Volumn 5, Issue 4, 2012, Pages 273-290

  Dinis Oliveira, Ricardo Jorge ^a,b,c,d,e   Carvalho, Félix ^e   Moreira, Roxana ^a   Duarte, José Alberto ^e   Proença, Jorge Brandão ^a,b   Santos, Agostinho ^c,d,f   Magalhães, Teresa ^c,d,e,f  

^a UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

^b CESPU   (Portugal)

^c University of Porto   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

^f Institute of Forensic Medicine   (Portugal)

Author keywords

"coma blisters"; Anthrax or clostridium contaminated heroin; Candidiasis; Dermatitis; Desomorphine; Heroin; Intra arterial administration; Non biological evidences; Opioid; Practices of phlebotomy; Respiratory depression; Skin "popping"; Tissue necrosis and ulceration; Tongue hyperpigmentation; Track marks and hemorrhages

Indexed keywords

CODEINE PHOSPHATE; DIAMORPHINE; NORBUPRENORPHINE; PENTAZOCINE; XENOBIOTIC AGENT;

ANAPHYLAXIS; ANTHRAX; ARTICLE; BLEEDING; BLISTER; CANDIDIASIS; CLOSTRIDIUM; COMA; DERMATITIS; EPIDERMOLYSIS; ERYTHRODERMA; FORENSIC SCIENCE; FORENSIC TOXICOLOGY; HAND DISEASE; HUMAN; HYPERPIGMENTATION; NECROTIZING FASCIITIS; OPIATE ADDICTION; PHLEBOTOMY; POLYMYOSITIS; PRIORITY JOURNAL; PTOSIS; RESPIRATION DEPRESSION; SCAR; SKIN ALLERGY; SKIN ULCER; SPOROTRICHOSIS; TISSUE NECROSIS; TONGUE DISEASE;

EID: 84873154598     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473711205040003     Document Type: Article

References (142)

1. Freye E, Levy JV, Eds. Opioids in medicine: a comprehensive review on the mode of action and the use of analgesics in different clinical pain states. Dordrecht: Springer 2008.
2. Martin WR. Pharmacology of opioids. Pharmacol Rev 1983; 35: 283-323.
3. Karch SB. Pharmacokinetics and pharmacodynamics of abused drugs. Boca Raton, FL: CRC Press 2008.
4. Elliott HW, Parker KD, Wright JA, Nomof N. Actions and metabolism of heroin administered by continuous intravenous infusion to man. Clin Pharmacol Ther 1971; 12: 806-14.
5. Oldendorf WH, Hyman S, Braun L, Oldendorf SZ. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 1972; 178: 984-986.
6. Selley DE, Cao CC, Sexton T, Schwegel JA, Martin TJ, Childers SR. mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetyl-morphine compared with morphine. Biochem Pharmacol 2001; 62: 447-455.
7. Inturrisi CE, Max MB, Foley KM, Schultz M, Shin SU, Houde RW. The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 1984; 310: 1213-1217.
8. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, Simon EJ. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 1983; 33 Suppl 1: 773-776.
9. Gyr E, Brenneisen R, Bourquin D, Lehmann T, Vonlanthen D, Hug I. Pharmacodynamics and pharmacokinetics of intravenously, orally and rectally administered diacetylmorphine in opioid dependents, a two-patient pilot study within a heroin-assisted treatment program. Int J Clin Pharmacol Ther 2000; 38: 486-491.
10. Rentsch KM, Kullak-Ublick GA, Reichel C, Meier PJ, Fattinger K. Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics. Clin Pharmacol Ther 2001; 70: 237-246.
11. Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol 2006; 1: 109-118.
12. Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH. Population pharmacokinetics of heroin and its major metabolites. Clin Pharmacokinet 2006; 45: 401-417.
13. Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH. Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients. Basic Clin Pharmacol Toxicol 2006; 98: 86-96.
14. Smith ML, Shimomura ET, Summers J, et al. Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol 2001; 25: 504-14.
15. EMCDDA. The state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union 2011.
16. Bargagli AM, Hickman M, Davoli M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2006; 16: 198-202.
17. Degenhardt L, Hall W, Warner-Smith M, Linskey M. Illicit drug use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, Eds. Comparative quantification of health risks Global and regional burden of disease attributable to major risk factors. Geneva World Health Organisation 2009.
18. Bloor M, Gannon M, Hay G, Jackson G, Leyland AH, McKeganey N. Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study. BMJ 2008; 337: a478.
19. Dinis-Oliveira RJ, Santos A, Magalhaes T. Foam Cone exuding from the mouth and nostrils following heroin overdose. Toxicol Mech Methods 2012; 22: 159-160.
20. Clatts MC, Giang le M, Goldsamt LA, Yi H. Novel heroin injection practices: implications for transmission of HIV and other bloodborne pathogens. Am J Prev Med 2007; 32: S226-33.
21. Tice AD. An unusual, nonhealing ulcer on the forearm. N Engl J Med 2002; 347: 1725-1726.
22. Del Giudice P. Cutaneous complications of intravenous drug abuse. Br J Dermatol 2004; 150: 1-10.
23. Sonmez ES, Yildiz K, Baygol EG, Su O, Ugurad ZI. Heroin-induced chronic symmetrical skin ulcers of the forearms in a young adult. Eur J Dermatol 2012; 22: 414.
24. Abidin MR, Gillinov MA, Topol BM, Francel TJ. Injection of illicit drugs into the granulation tissue of chronic ulcers. Ann Plast Surg 1990; 24: 268-70.
25. Benomran F. Postmortem sole incisions - a new sign of heroin overdose? J Forensic Leg Med 2008; 15: 59-63.
26. Maher L, Ho HT. Overdose beliefs and management practices among ethnic Vietnamese heroin users in Sydney, Australia. Harm Reduct J 2009; 6: 6.
27. Conde-Taboada A, De la Torre C, Garcia-Doval I, Abalde MT, Mayo E, Gonzalez-Sixto B, Cruces M. Scalp necrosis and ulceration secondary to heroin injection. Int J Dermatol 2006; 45: 1135-1136.
28. Hengge UR, Beiderlinden M, Otterbach F, Groeben H, Nast-Kolb D, Mehnert WH, Peters J, Schmid KW. 31-year-old injection drug user with massive skin necrosis and shock. Dermatology 2003; 206: 169-171.
29. Williams AM, Southern SJ. Conflicts in the treatment of chronic ulcers in drug addicts--case series and discussion. Br J Plast Surg 2005; 58: 997-999.
30. Alvi A, Ravichandran D. An unusual case of breast ulceration. Breast 2006; 15: 115-116.
31. Stromberg PE, Montgomery JY, Evans TC, Wills BK. Woman with a hand ulcer. Clin Toxicol (Phila) 2012; 50: 221-222.
32. De D, Dogra S, Kanwar AJ. Pentazocine-induced leg ulcers and fibrous papules. Indian J Dermatol Venereol Leprol 2007; 73: 112-113.
33. Clemente-Ruiz de Almiron A, Serrano-Ortega S. Skin ulcerations due to pentazocine on both thighs. J Eur Acad Dermatol Venereol 2009; 23: 857-8.
34. Parks DL, Perry HO, Muller SA. Cutaneous complications of pentazocine injections. Arch Dermatol 1971; 104: 231-235.
35. Swanson DW, Weddige RL, Morse RM. Hospitalized pentazocine abusers. Mayo Clin Proc 1973; 48: 85-93.
36. Prasad HR, Khaitan BK, Ramam M, Sharma VK, Pandhi RK, Agarwal S, Dhawan A, Jain R, Singh MK. Diagnostic clinical features of pentazocine-induced ulcers. Int J Dermatol 2005; 44: 910-5.
37. Jain A, Bhattacharya SN, Singal A, Baruah MC, Bhatia A. Pentazocine induced widespread cutaneous and myo-fibrosis. J Dermatol 1999; 26: 368-370.
38. Kim HA, Song YW. Polymyositis developing after prolonged injections of pentazocine. J Rheumatol 1996; 23: 1644-1646.
39. Girolami A, Cella G. Acute superficial phlebitis in a patient with hemophilia A. Probably an iatrogenic effect. Acta Haematol 1972; 48: 307-311.
40. Schlicher JE, Zuehlke RL, Lynch PJ. Local changes at the site of pentazocine injection. Arch Dermatol 1971; 104: 90-91.
41. Asfar SK, Baraka A, Juma T, Ma'Rafie A, Aladeen T, Al Sayer H. Necrotizing fasciitis. Br J Surg 1991; 78: 838-840.
42. Pagnini D, Colizzi L, Giacomina A, et al. A devastating case of heroin-associated necrotizing fasciitis of the upper limb with bone exposure. A useful method of treatment. J Plast Reconstr Aesthet Surg 2009; 62: e151-152.
43. Spiro M. A 30-year-old woman with acute leg pain. J Emerg Nurs 2011; 37: 252-3.
44. Bellapianta JM, Ljungquist K, Tobin E, Uhl R. Necrotizing fasciitis. J Am Acad Orthop Surg 2009; 17: 174-182.
45. Dunbar NM, Harruff RC. Necrotizing fasciitis: manifestations, microbiology and connection with black tar heroin. J Forensic Sci 2007; 52: 920-923.
46. Regev A, Weinberger M, Fishman M, Samra Z, Pitlik SD. Necrotizing fasciitis caused by Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1998; 17: 101-103.
47. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-53.
48. Bucardo J, Brouwer KC, Magis-Rodriguez C, et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend 2005; 79: 281-293.
49. Del Giudice P, Vandenbos F, Boissy C, et al. Cutaneous complications of direct intra-arterial injections in drug addicts. Acta Derm Venereol 2005; 85: 451-2.
50. Andresz V, Marcantoni N, Binder F, et al. Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis. Addiction 2006; 101: 1347-51.
51. Neviaser RJ, Butterfield WC, Wieche DR. The puffy hand of drug addiction: a study of the pathogenesis. J Bone Joint Surg Am 1972; 54: 629-633.
52. Agarwal S, Trivedi M. Cutaneous complications of pentazocine abuse. Indian J Dermatol Venereol Leprol 2007; 73: 280.
53. Goyal V, Chawla JM, Balhara YP, Shukla G, Singh S, Behari M. Calcific myofibrosis due to pentazocine abuse: a case report. J Med Case Rep 2008; 2: 160.
54. Steiner JC, Winkelman AC, De Jesus PV, Jr. Pentazocine-induced myopathy. Arch Neurol 1973; 28: 408-409.
55. Oh SJ, Rollins JL, Lewis I. Pentazocine-induced fibrous myopathy. JAMA 1975; 231: 271-273.
56. Das CP, Thussu A, Prabhakar S, Banerjee AK. Pentazocine-induced fibromyositis and contracture. Postgrad Med J 1999; 75: 361-362.
57. Touraine A. Les dermatoses de l'opium. Revue Méd 1936; 53: 449-460.
58. Corson EF, Rouse GP, Jr. Contact dermatitis from morphine; a series of cases among workers in a drug factory. Pa Med J 1946; 49: 968-9670.
59. de Cuyper C, Goeteyn M. Systemic contact dermatitis from subcutaneous hydromorphone. Contact Dermatitis 1992; 27: 220-223.
60. de Groot AC, Conemans J. Allergic urticarial rash from oral codeine. Contact Dermatitis 1986; 14: 209-214.
61. Kaae J, Menne T, Thyssen JP. Systemic contact dermatitis following oral exposure to tramadol in a patient with allergic contact dermatitis caused by buprenorphine. Contact Dermatitis 2012; 66: 106-107.
62. Muller FM, Arseculeratne G, Evans A, Fleming C. Necrolytic migratory erythema in an opiate-dependent patient. Clin Exp Dermatol 2008; 33: 40-42.
63. Gontijo B, Bittencourt FV, Lourenço LFS. Skin manifestations of illicit drug use. An Bras Dermatol 2006; 81: 307-317.
64. Rodriguez A, Barranco R, Latasa M, de Urbina JJ, Estrada JL. Generalized dermatitis due to codeine. Cross-sensitization among opium alkaloids. Contact Dermatitis 2005; 53: 240.
65. Hogen Esch AJ, van der Heide S, van den Brink W, van Ree JM, Bruynzeel DP, Coenraads PJ. Contact allergy and respiratory/mucosal complaints from heroin (diacetylmorphine). Contact Dermatitis 2006; 54: 42-49.
66. Edston E, van Hage-Hamsten M. Anaphylactoid shock--a common cause of death in heroin addicts? Allergy 1997; 52: 950-954.
67. Cygan J, Trunsky M, Corbridge T. Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest 2000; 117: 272-275.
68. Gooch I, Gwinnutt C. Anaphylaxis to intrathecal diamorphine. Resuscitation 2006; 70: 470-473.
69. Edston E, van Hage-Hamsten M. beta-Tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int 1998; 9 3: 135-142.
70. Fineschi V, Cecchi R, Centini F, Reattelli LP, Turillazzi E. Immunohistochemical quantification of pulmonary mast-cells and post-mortem blood dosages of tryptase and eosinophil cationic protein in 48 heroin-related deaths. Forensic Sci Int 2001; 120: 189-94.
71. Shaikh WA. Allergy to heroin. Allergy 1990; 45: 555-556.
72. Coenraads PJ, Hogen Esch AJ, Prevoo RL. Occupational contact dermatitis from diacetylmorphine (heroin). Contact Dermatitis 2001; 45: 114.
73. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant. Anesthesiology 1989; 71: 489-494.
74. Matsuzawa Y, Fujishima S, Nakada T, Iijima M. Erythema multiforme major putatively induced by dihydrocodeine phosphate. Clin Exp Dermatol 2010; 35: 673-674.
75. Arai S, Mukai H. Erythroderma induced by morphine sulfate. J Dermatol 2011; 38: 288-289.
76. Westerhof W, Wolters EC, Brookbakker JT, Boelen RE, Schipper ME. Pigmented lesions of the tongue in heroin addicts--fixed drug eruption. Br J Dermatol 1983; 109: 605-610.
77. Piede J, Wallace E. Coma bullae: associations beyond medications. Mayo Clin Proc 2011; 86: e5.
78. Taniguchi Y, Wada Y, Takahashi M, Harada M, Shimizu M. Multiple bullae and paresis after drug-induced coma. Acta Derm Venereol 1991; 71: 536-538.
79. Rocha J, Pereira T, Ventura F, Pardal F, Brito C. Coma Blisters. Case Rep Dermatol 2009; 1: 66-70.
80. Waring WS, Sandilands EA. Coma blisters. Clin Toxicol (Phila) 2007; 45: 808-9.
81. Geelhoed GW. Surgical (and medical) sequelae of drug addiction. Med Ann Dist Columbia 1974; 43: 307-316.
82. Klonaris C, Katsargyris A, Papapetrou A, et al. Infected femoral artery pseudoaneurysm in drug addicts: the beneficial use of the internal iliac artery for arterial reconstruction. J Vasc Surg 2007; 45: 498-504.
83. Arora S, Weber MA, Fox CJ, Neville R, Lidor A, Sidawy AN. Common femoral artery ligation and local debridement: a safe treatment for infected femoral artery pseudoaneurysms. J Vasc Surg 2001; 33: 990-993.
84. Tan KK, Chen K, Chia KH, Lee CW, Nalachandran S. Surgical management of infected pseudoaneurysms in intravenous drug abusers: single institution experience and a proposed algorithm. World J Surg 2009; 33: 1830-1835.
85. Peirce C, Coffey JC, O'Grady H, Aly S, O'Malley K, O'Donohoe M. The management of mycotic femoral pseudoaneurysms in intravenous drug abusers. Ann Vasc Surg 2009; 23: 345-349.
86. Chan YC, Burnand KG. Management of septic groin complications and infected femoral false aneurysms in intravenous drug abusers. Br J Surg 2006; 93: 781-2.
87. Welch GH, Reid DB, Pollock JG. Infected false aneurysms in the groin of intravenous drug abusers. Br J Surg 1990; 77: 330-333.
88. Coughlin PA, Mavor AI. Arterial consequences of recreational drug use. Eur J Vasc Endovasc Surg 2006; 32: 389-396.
89. Mullan MJ, Magowan H, Weir CD. Femoral artery necrosis due to parenteral intravascular drug misuse: a case report and literature review. Ulster Med J 2008; 77: 203-204.
90. Pierre-Alexandre J, Francois le P, Abdellah S, Karim T, Christian de G, Frederique C. An unusual case of livedoid and necrotic lesions in a drug addict. Am J Dermatopathol 2007; 29: 72-74.
91. Bisbe J, Miro JM, Latorre X, et al. Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review. Clin Infect Dis 1992; 15: 910-923.
92. Dupont B, Drouhet E. Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients. J Infect Dis 1985; 152: 577-591.
93. Podzamczer D, Ventin M, Sauca G, Fernandez-Viladrich P, Martin R, Gudiol F. Contaminated lemons as possible source of infection in heroin abusers with disseminated candidiasis. Eur J Clin Microbiol 1986; 5: 477.
94. Bougnoux ME, Dupont C, Turner L, Rouveix E, Dorra M, Nicolas-Chanoine MH. Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict. Eur J Clin Microbiol Infect Dis 1997; 16: 598-600.
95. Recio C, Pique E, Lluch J, Vidal JM. [Candida folliculitis in intravenous drug users]. Enferm Infecc Microbiol Clin 2003; 21: 386-387.
96. Booth MG, Hood J, Brooks TJ, Hart A. Anthrax infection in drug users. Lancet 2010; 375: 1345-6.
97. Powell AG, Crozier JE, Hodgson H, Galloway DJ. A case of septicaemic anthrax in an intravenous drug user. BMC Infect Dis 2011; 11: 21.
98. Ringertz SH, Hoiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, Fossum K. Injectional anthrax in a heroin skin-popper. Lancet 2000; 356: 1574-1575.
99. Beaumont G. Anthrax in a Scottish intravenous drug user. J Forensic Leg Med 2010; 17: 443-445.
100. Johns N, Cooper D, Terrace J. An unusual case of peritonitis in an intravenous drug user. Gastroenterology 2011; 141: 435-6, 780-781.
101. Kanafani ZA, Ghossain A, Sharara AI, Hatem JM, Kanj SS. Endemic gastrointestinal anthrax in 1960s Lebanon: clinical manifestations and surgical findings. Emerg Infect Dis 2003; 9: 520-525.
102. Dancer SJ, McNair D, Finn P, Kolsto AB. Bacillus cereus cellulites from contaminated heroin. J Med Microbiol 2002; 51: 278-281.
103. Mandell GL, Bennett's JE, Dolin R. Principles and Practice of Infectious Diseases. Philadelphia, PA: Churchill Livingstone 2005.
104. Davis LE, King MK. Wound botulism from heroin skin popping. Curr Neurol Neurosci Rep 2008; 8: 462-468.
105. Brett MM, Hood J, Brazier JS, Duerden BI, Hahne SJ. Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiol Infect 2005; 133: 575-582.
106. Brett MM, Hallas G, Mpamugo O. Wound botulism in the UK and Ireland. J Med Microbiol 2004; 53: 555-561.
107. Passaro DJ, Werner SB, McGee J, Mac Kenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998; 279: 859-863.
108. Iqbal N. Tetanus in i.v. heroin users. Ann Saudi Med 2001; 21: 296-299.
109. Talan DA, Moran GJ. Tetanus among injecting-drug users-- California, 1997. Ann Emerg Med 1998; 32: 385-386.
110. Kimura AC, Higa JI, Levin RM, Simpson G, Vargas Y, Vugia DJ. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 2004; 38: e87-e91.
111. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL. Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354: 462-471.
112. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001; 285: 1059-1070.
113. Chang SL, Chung WH, Huang YH, Hong HS. Bilateral sporotrichoid lymphocutaneous dermatosis in a drug abuser: case report and review of the literature. Am J Clin Dermatol 2008; 9: 393-395.
114. Skowronek R, Celinski R, Chowaniec C. Crocodile - new dangerous designer drug of abuse from the East. Clin Toxicol (Phila) 2012; 50: 269.
115. Small L, Yuen K, Eilers L. The catalytic hydrogenation of the halogenomorphides: Dihydrodesoxymorphine-D1. J Am Coll Cardiol 1933; 55: 3863-3870.
116. Gahr M, Freudenmann RW, Hiemke C, Gunst IM, Connemann BJ, Schonfeldt-Lecuona C. Krokodil-revival of an old drug with new problems. Subst Use Misuse 2012.
117. Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci 1993; 53: 1391-1399.
118. DiMaio VJM, DiMaio D. Forensic pathology. Boca Raton, FL: CRC Press 2001.
119. Henssge C, Madea B. Estimation of the time since death in the early post-mortem period. Forensic Sci Int 2004; 144: 167-175.
120. Henssge C, Madea B. Estimation of the time since death. Forensic Sci Int 2007; 165: 182-184.
121. Pounder DJ. Postmortem interval. In: Payne-James J, Byard RW, Corey TS, Henderson C, Eds. Encyclopedia of forensic and legal medicine. Oxford: Elsevier 2005, pp. 482-488.
122. Spitz WU, Spitz D. Spitz and Fisher's medicolegal investigation of death: guidelines for the application of pathology to crime investigation. Springfield, IL: Charles C Thomas 2006.
123. Prahlow J. Forensic pathology for police, death investigators, attorneys, and forensic scientists. Humana Press 2010.
124. Sieger J, Saukko P, Knupfer G. Encyclopedia of forensic sciences. San Diego: Academic Press 2000.
125. Jumbelic MI. Deaths with transdermal fentanyl patches. Am J Forensic Med Pathol 2009.
126. Frolich MA, Giannotti A, Modell JH. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 2001; 93: 647-648.
127. Kramer C, Tawney M. A fatal overdose of transdermally administered fentanyl. J Am Osteopath Assoc 1998; 98: 385-386.
128. Martin TL, Woodall KL, McLellan BA. Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004). J Anal Toxicol 2006; 30: 603-610.
129. Marquardt KA, Tharratt RS. Inhalation abuse of fentanyl patch. J Toxicol Clin Toxicol 1994; 32: 75-78.
130. Lilleng PK, Mehlum LI, Bachs L, Morild I. Deaths after intravenous misuse of transdermal fentanyl. J Forensic Sci 2004; 49: 1364-1366.
131. Kuhlman JJ, Jr., McCaulley R, Valouch TJ, Behonick GS. Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 2003; 27: 499-504.
132. Reeves MD, Ginifer CJ. Fatal intravenous misuse of transdermal fentanyl. Med J Aust 2002; 177: 552-553.
133. Carson HJ, Knight LD, Dudley MH, Garg U. A fatality involving an unusual route of fentanyl delivery: Chewing and aspirating the transdermal patch. Leg Med (Tokyo) 2010; 12: 157-159.
134. Dinis-Oliveira RJ, Carvalho F, Duarte JA, Proenca JB, Santos A, Magalhaes T. Clinical and forensic signs related to cocaine abuse. Curr Drug Abuse Rev 2012; 5: 64-83.
135. Dinis-Oliveira RJ, Carvalho F, Duarte JA, et al. Collection of biological samples in forensic toxicology. Toxicol Mech Methods 2010; 20: 363-414.
136. Habal R. Heroine toxicity. Medsape reference - drugs, diseases & procedures, http://emedicine.medscape.com/article/166464-media 2011.
137. Authors not listed. Skin popping. http://www.dermaamin.com/site/atlas-of-dermatology/18-s/1142-skin-popping.html
138. Enomoto M, Ochi M, Teramae K, Kamo R, Taguchi S, Yamane T. Codeine phosphate-induced hypersensitivity syndrome. Ann Pharmacother 2004; 38: 799-802.
139. Schneider P, Duong TA, Ortonne N, Bagot M, Bouaziz JD. Livedoid and necrotic skin lesions due to intra-arterial buprenorphine injections evidenced by maltese cross-shaped histologic bodies. Arch Dermatol 2010; 146: 208-209.
140. Galldiks N, Nolden-Hoverath S, Kosinski CM, et al. Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin. Neurocrit Care 2007; 6: 30-34.
141. Sam AH, Beynon HL. Images in clinical medicine: Wound botulism. N Engl J Med 2010; 363: 2444.
142. Pollak S, Saukko P. Atlas of forensic medicine. Amsterdam: Elsevier 2003.